R&D

Pfizer/Lilly non-opioid pain drug hits mark in phase 3 trial

https://pharmaphorum.com/news/pfizer-lilly-tanezumab-pain-drug-hits-mark-in-phase-3-trial/

PureTech signs potential $1bn exosome deal with Roche

https://pharmaphorum.com/news/puretech-signs-potential-1bn-exosome-deal-with-roche/

UK government kick-starts AMR research with £10m grant

https://pharmaphorum.com/news/uk-government-kick-starts-amr-research-10m-grant/

AZ hopes diabetes drug could be as effective as gastric band

https://pharmaphorum.com/news/az-hopes-diabetes-drug-could-be-as-effective-as-gastric-band/

Herpes virus discoveries could lead to new drugs

https://pharmaphorum.com/news/herpes-virus-discoveries-could-lead-to-new-drugs/

Forendo joins race to develop endometriosis drugs

https://pharmaphorum.com/news/forendo-joins-race-to-develop-endometriosis-drugs/

Prothena axes half its staff after phase 3 catastrophe

https://pharmaphorum.com/news/prothena-axes-staff-phase-3-catastrophe/

https://pharmaphorum.com/partner-content/wellcome-genome-campus-hackathon-2-3-july/

Discover the Future of Pharmaceutical Technology Within Lyophilisation

https://pharmaphorum.com/partner-content/discover-the-future-of-pharmaceutical-technology-within-lyophilisation/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search